• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶抑制剂在心肌梗死后减轻心室重构中的作用。

The role of angiotensin-converting enzyme inhibitors in reducing ventricular remodeling after myocardial infarction.

作者信息

Fara A M

机构信息

Methodist Hospital of Indiana, Inc., Indianapolis.

出版信息

J Cardiovasc Nurs. 1993 Oct;8(1):32-48. doi: 10.1097/00005082-199310000-00006.

DOI:10.1097/00005082-199310000-00006
PMID:8106896
Abstract

Ventricular remodeling is a pathologic change in the size and shape of the heart after myocardial infarction. Human and animal studies have described the mechanisms responsible for the thinning and enlargement that progresses for years beyond the initial infarction. As a result of elevations in preload and afterload, ventricular pressures increase, and changes occur in both the infarcted and uninfarcted regions of the ventricle, increasing overall heart size. Recent investigation has demonstrated that the initiation of angiotensin-converting enzyme (ACE) inhibitor drugs after myocardial infarction reduces both systolic and diastolic wall stresses, thereby averting changes in heart size. These findings are significant, as increases in heart size and ventricular volumes have proved to be powerful predictors of early mortality after myocardial infarction.

摘要

心室重构是心肌梗死后心脏大小和形状的病理性改变。人体和动物研究已经描述了导致心脏变薄和扩大的机制,这种变化在初始梗死数年之后仍会持续发展。由于前负荷和后负荷升高,心室压力增加,心室梗死区和未梗死区均发生改变,导致心脏整体增大。最近的研究表明,心肌梗死后开始使用血管紧张素转换酶(ACE)抑制剂药物可降低收缩期和舒张期壁应力,从而避免心脏大小改变。这些发现意义重大,因为心脏大小和心室容积增加已被证明是心肌梗死后早期死亡率的有力预测指标。

相似文献

1
The role of angiotensin-converting enzyme inhibitors in reducing ventricular remodeling after myocardial infarction.血管紧张素转换酶抑制剂在心肌梗死后减轻心室重构中的作用。
J Cardiovasc Nurs. 1993 Oct;8(1):32-48. doi: 10.1097/00005082-199310000-00006.
2
Ventricular dilatation and remodeling after myocardial infarction.心肌梗死后的心室扩张与重构。
Mayo Clin Proc. 1994 Jul;69(7):664-74. doi: 10.1016/s0025-6196(12)61345-7.
3
Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.血管紧张素转换酶抑制剂对心肌梗死后心室重构和生存率的影响。
Ann Pharmacother. 1993 Jun;27(6):755-66. doi: 10.1177/106002809302700617.
4
Ventricular remodeling following myocardial infarction: a description of the pathologic process, current investigation, and suggested therapy.心肌梗死后的心室重构:病理过程描述、当前研究及建议治疗方法
Crit Care Nurs Clin North Am. 1992 Jun;4(2):325-37.
5
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.心肌梗死后的心室重构。实验观察与临床意义。
Circulation. 1990 Apr;81(4):1161-72. doi: 10.1161/01.cir.81.4.1161.
6
Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction.
Annu Rev Physiol. 1995;57:805-26. doi: 10.1146/annurev.ph.57.030195.004105.
7
Left ventricular remodeling after acute myocardial infarction: clinical course and beneficial effects of angiotensin-converting enzyme inhibition.
Am Heart J. 1991 Apr;121(4 Pt 1):1194-202. doi: 10.1016/0002-8703(91)90682-8.
8
Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.早期开始的血管紧张素转换酶抑制和血管紧张素AT1受体亚型阻断对心肌梗死大鼠的慢性影响:缓激肽的作用
Cardiovasc Res. 1998 Aug;39(2):401-12. doi: 10.1016/s0008-6363(98)00090-x.
9
Angiotensin converting enzyme inhibition therapy following myocardial infarction. Rationale for clinical trials.
Herz. 1991 Sep;16 Spec No 1:278-82.
10
[Physiopathology of left ventricular remodeling after myocardial infarction].[心肌梗死后左心室重构的病理生理学]
Arch Mal Coeur Vaiss. 1991 Dec;84 Spec No 4:43-9.